Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas

作者: Darko Castven , Michael Fischer , Diana Becker , Stefan Heinrich , Jesper B. Andersen

DOI: 10.18632/ONCOTARGET.16231

关键词:

摘要: // Darko Castven 1,* , Michael Fischer Diana Becker 1 Stefan Heinrich 2 Jesper B. Andersen 3 Dennis Strand Martin F. Sprinzl Susanne Carolin Czauderna Stefanie Heilmann-Heimbach 4 Stephanie Roessler 5 Arndt Weinmann Marcus A. Worns Snorri S. Thorgeirsson 6 Peter R. Galle Matthias Matter 7 Hauke Lang and Jens U. Marquardt Department of Medicine, Johannes Gutenberg University, Mainz, Germany Surgery, Health Medical Science, Biotech Research Innovation Centre, University Copenhagen, Denmark Genomics, Institute Human Genetics, Life & Brain Center, Bonn, Pathology, Hospital Heidelberg, Laboratory Experimental Carcinogenesis, Center for Cancer Research, National Institute, NIH, Bethesda, MD, USA Basel, Switzerland * These authors have contributed equally to this work Correspondence to: Marquardt, email: Keywords : liver cancer, microenvironment, hepatocarcinogenesis, stemness features, field effect Received February 22, 2017 Accepted March 03, Published 15, Abstract Hepatocellular Carcinoma (HCC) commonly develops in chronically damaged tissues. The resulting regenerative inflammatory processes create an adverse milieu that promotes tumor-initiation progression. A better understanding the hepatic tumor-microenvironment interaction might infer profound therapeutic implications. Integrative whole genome transcriptome analyses different tumor regions, invasive border tumor-surrounding (SL) were performed identify associated molecular alterations integrated with our existing HCC database. Expression levels localization established CSC markers assessed pre-neoplastic lesions confirmed two independent patient cohorts using qRT-PCR, immunohistochemistry immunofluorescence. Our results indicate genomic transcriptomic profiles between SL regions are quite distinct. Progressive increase genetic activation pathways related proliferation as well apoptosis observed tissue, while was present cirrhotic continuously decreased from HCC. Interestingly, characterized by EMT-related gene sets pro-survival signaling. Consistently, integration expression signatures databases containing 300 HCCs revealed predictive survival. Prognostic significance permissive microenvironment be a consequence pro-oncogenic is caused chronic processes. Activation key oncogenic features immune-response signaling indicates cross-talk promising and/or preventive target.

参考文章(42)
Tania Roskams, Valeer Desmet, Ductular reaction and its diagnostic significance. Seminars in Diagnostic Pathology. ,vol. 15, pp. 259- 269 ,(1998)
Stefan M. Brunner, Christoph Rubner, Rebecca Kesselring, Maria Martin, Eva Griesshammer, Petra Ruemmele, Thomas Stempfl, Andreas Teufel, Hans J. Schlitt, Stefan Fichtner-Feigl, Tumor-infiltrating, interleukin-33-producing effector-memory CD8+T cells in resected hepatocellular carcinoma prolong patient survival Hepatology. ,vol. 61, pp. 1957- 1967 ,(2015) , 10.1002/HEP.27728
David Y Zhang, Nicolas Goossens, Jinsheng Guo, Ming-Chao Tsai, Hsin-I Chou, Civan Altunkaynak, Angelo Sangiovanni, Massimo Iavarone, Massomo Colombo, Masahiro Kobayashi, Hiromitsu Kumada, Augusto Villanueva, Josep M Llovet, Yujin Hoshida, Scott L Friedman, A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection Gut. ,vol. 65, pp. 1754- 1764 ,(2016) , 10.1136/GUTJNL-2015-309655
Virginia Hernandez–Gea, Sara Toffanin, Scott L. Friedman, Josep M. Llovet, Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma Gastroenterology. ,vol. 144, pp. 512- 527 ,(2013) , 10.1053/J.GASTRO.2013.01.002
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme De Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F Greten, Peter R Galle, Jean-François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, Marius Moscovici, Dimitris Voliotis, Jordi Bruix, None, Sorafenib in Advanced Hepatocellular Carcinoma The New England Journal of Medicine. ,vol. 359, pp. 378- 390 ,(2008) , 10.1056/NEJMOA0708857
Tom Luedde, Robert F. Schwabe, NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma Nature Reviews Gastroenterology & Hepatology. ,vol. 8, pp. 108- 118 ,(2011) , 10.1038/NRGASTRO.2010.213
Linheng Li, William B. Neaves, Normal Stem Cells and Cancer Stem Cells: The Niche Matters: Figure 1. Cancer Research. ,vol. 66, pp. 4553- 4557 ,(2006) , 10.1158/0008-5472.CAN-05-3986
Guobin He, Debanjan Dhar, Hayato Nakagawa, Joan Font-Burgada, Hisanobu Ogata, Yuhong Jiang, Shabnam Shalapour, Ekihiro Seki, Shawn E. Yost, Kristen Jepsen, Kelly A. Frazer, Olivier Harismendy, Maria Hatziapostolou, Dimitrios Iliopoulos, Atsushi Suetsugu, Robert M. Hoffman, Ryosuke Tateishi, Kazuhiko Koike, Michael Karin, Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling Cell. ,vol. 155, pp. 384- 396 ,(2013) , 10.1016/J.CELL.2013.09.031
Michael F Clarke, John E Dick, Peter B Dirks, Connie J Eaves, Catriona HM Jamieson, D Leanne Jones, Jane Visvader, Irving L Weissman, Geoffrey M Wahl, None, Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research. ,vol. 66, pp. 9339- 9344 ,(2006) , 10.1158/0008-5472.CAN-06-3126
Feng Li, Benjamin Tiede, Joan Massagué, Yibin Kang, Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research. ,vol. 17, pp. 3- 14 ,(2007) , 10.1038/SJ.CR.7310118